Abstract
MHC class I molecules present small intracellular generated fragments to the outside surveying immune system. This is the result of a series of biochemical processes involving biosynthesis, degradation, translocation, intracellular transport, diffusion, and many more. Critical intermediates and end products of this cascade of events are peptides. The peptides are generated by the proteasome, degraded by peptidases unless transported into the ER where another peptidase and MHC class I molecules are waiting. Unless peptides bind to MHC class I molecules, they are released from the ER and enter the cytoplasm by a system resembling the ERAD pathway in many aspects. The cycle of peptides over the ER membrane with the proteasome at the input site and peptidases or MHC class I molecules on the output site are central in the MHC class I antigen presentation pathway and this review.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abele R, Tampe R (2004) The ABCs of immunology: structure and function of TAP, the transporter associated with antigen processing. Physiology (Bethesda) 19:216–224
Arnold D, Faath S, Rammensee H, Schild H (1995) Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182:885–889
Balow RM, Tomkinson B, Ragnarsson U, Zetterqvist O (1986) Purification, substrate specificity, classification of tripeptidyl peptidase II. J Biol Chem 261:2409–2417
Barelli H, Ahmad S, Kostka P, Fox JA, Daniel EE, Vincent JP, Checler F (1989) Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivation. Peptides 10:1055–1061
Basta S, Chen W, Bennink JR, Yewdell JW (2002) Inhibitory effects of cytomegalovirus proteins US2 and US11 point to contributions from direct priming and cross-priming in induction of vaccinia virus-specific CD8(+) T cells. J Immunol 168:5403–5408
Beck S, Kelly A, Radley E, Khurshid F, Alderton RP, Trowsdale J (1992) DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing. J Mol Biol 228:433–441
Ben-Arieh SV, Zimerman B, Smorodinsky NI, Yaacubovicz M, Schechter C, Bacik I, Gibbs J, Bennink JR, Yewdell JW, Coligan JE et al (2001) Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis. J Virol 75:10557–10562
Bouvier M, Wiley DC (1994) Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265:398–402
Breslin HJ, Miskowski TA, Kukla MJ, Leister WH, De Winter HL, Gauthier DA, Somers MV, Peeters DC, Roevens PW (2002) Design, synthesis, tripeptidyl peptidase II inhibitory activity of a novel series of (S)-2,3-dihydro-2-(4-alkyl-1H-imidazol-2-yl)-1H-indoles. J Med Chem 45:5303–5310
Brocke P, Armandola E, Garbi N, Hammerling GJ (2003) Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes. Eur J Immunol 33:411–421
Cascio P, Hilton C, Kisselev AF, Rock KL, Goldberg AL (2001) 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide. EMBO J 20:2357–2366
Castelli C, Rivoltini L, Rini F, Belli F, Testori A, Maio M, Mazzaferro V, Coppa J, Srivastava PK, Parmiani G (2004) Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother 53:227–233
Chen M, Abele R, Tampe R (2004) Functional non-equivalence of ABC signature motifs in the transporter associated with antigen processing (TAP). J Biol Chem 279:46073–46081
Chen W, Bennink JR, Yewdell JW (2001) Quantitating presentation of MHC class I-restricted antigens. Methods Mol Biol 156:245–254
Chien HC, Lin LL, Chao SH, Chen CC, Wang WC, Shaw CY, Tsai YC, Hu HY, Hsu WH (2002) Purification, characterization, genetic analysis of a leucine aminopeptidase from Aspergillus sojae. Biochim Biophys Acta 1576:119–126
Cresswell P, Bangia N, Dick T, Diedrich G (1999) The nature of the MHC class I peptide loading complex. Immunol Rev 172:21–28
Dauch P, Barelli H, Vincent JP, Checler F (1991) Fluorimetric assay of the neurotensindegrading metalloendopeptidase, endopeptidase 24.16. Biochem J 280:421–426
Elliott T, Smith M, Driscoll P, McMichael A (1993) Peptide selection by class Imolecules of the major histocompatibility complex. Curr Biol 3:854–866
Fruci D, Niedermann G, Butler RH, van Endert PM (2001) Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum. Immunity 15:467–476
Galocha B, Hill A, Barnett BC, Dolan A, Raimondi A, Cook RF, Brunner J, McGeoch DJ, Ploegh HL (1997) The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex(MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J Exp Med 185:1565–1572
Garbi N, Tan P, Diehl AD, Chambers BJ, Ljunggren HG, Momburg F, Hammerling GJ (2000) Impaired immune responses and altered peptide repertoire in tapasindeficient mice. Nat Immunol 1:234–238
Geier E, Pfeifer G, Wilm M, Lucchiari-Hartz M, Baumeister W, Eichmann K, Niedermann G (1999) A giant protease with potential to substitute for some functions of the proteasome. Science 283:978–981
Gillece P, Luz JM, Lennarz WJ, de La Cruz FJ, Romisch K (1999) Export of a cysteinefree misfolded secretory protein from the endoplasmic reticulumfor degradation requires interaction with protein disulfide isomerase. J Cell Biol 147:1443–1456
Grandea AG 3rd, Androlewicz MJ, Athwal RS, Geraghty DE, Spies T (1995) Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270:105–108
Gromme M, van der Valk R, Sliedregt K, Vernie L, Liskamp R, Hammerling G, Koopmann JO, Momburg F, Neefjes J (1997) The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics. Eur J Immunol 27:898–904
Gu YQ, Walling LL (2002) Identification of residues critical for activity of the wound-induced leucine aminopeptidase(LAP-A) of tomato. Eur J Biochem 269:1630–1640
Hampton RY (2002) ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14:476–482
Heemels MT, Schumacher TN, Wonigeit K, Ploegh HL (1993) Peptide translocation by variants of the transporter associated with antigen processing. Science 262:2059–2063
Hewitt EW, Gupta SS, Lehner PJ (2001) The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 20:387–396
Hui M, Hui KS (2003) Neuron-specific aminopeptidase and puromycin-sensitive aminopeptidase in rat brain development. Neurochem Res 28:855–860
Kakuta H, Koiso Y, Nagasawa K, Hashimoto Y (2003) Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells. Bioorg Med Chem Lett 13:83–86
Kane RC, Bross PF, Farrell AT, Pazdur R (2003) Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 8:508–513
Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A (1992) Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature 355:641–644
Klein I, Sarkadi B, Varadi A (1999) An inventory of the human ABC proteins. Biochim Biophys Acta 1461:237–262
Kondagunta GV, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, Mazumdar M, Motzer RJ (2004) Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol 22:3720–3725
Koopmann JO, Albring J, Huter E, Bulbuc N, Spee P, Neefjes J, Hammerling GJ, Momburg F (2000) Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 13:117–127
Koopmann JO, Post M, Neefjes JJ, Hammerling GJ, Momburg F (1996) Translocation of long peptides by transporters associated with antigen processing (TAP). Eur J Immunol 26:1720–1728
Koppers-Lalic D, Rychlowski M, van Leeuwen D, Rijsewijk FA, Ressing ME, Neefjes JJ, Bienkowska-Szewczyk K, Wiertz EJ (2003) Bovine herpesvirus 1 interferes with TAP-dependent peptide transport and intracellular trafficking of MHC class I molecules in human cells. Arch Virol 148:2023–2037
Kuo LY, Hwang GY, Lai YJ, Yang SL, Lin LL (2003) Overexpression, purification, characterization of the recombinant leucine aminopeptidase II of Bacillus stearother-mophilus. Curr Microbiol 47:40–45
Lammert E, Arnold D, Nijenhuis M, Momburg F, Hammerling GJ, Brunner J, Stevanovic S, Rammensee HG, Schild H (1997a) The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP. Eur J Immunol 27:923–927
Lammert E, Stevanovic S, Brunner J, Rammensee HG, Schild H (1997b) Protein disulfide isomerase is the dominant acceptor for peptides translocated into the endoplasmic reticulum. Eur J Immunol 27:1685–1690
Millican PE, Kenny AJ, Turner AJ (1991) Purification and properties of a neurotensin-degrading endopeptidase from pig brain. Biochem J 276:583–591
Momburg F, Roelse J, Hammerling GJ, Neefjes JJ (1994a) Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J Exp Med 179:1613–1623
Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, Neefjes JJ (1994b) Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367:648–651
Neefjes JJ, Momburg F, Hammerling GJ (1993) Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769–771
Neefjes JJ, Ploegh HL (1988) Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol 18:801–810
Neisig A, Roelse J, Sijts AJ, Ossendorp F, Feltkamp MC, Kast WM, Melief CJ, Neefjes JJ (1995) Major differences in transporter associatedwith antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences. J Immunol 154:1273–1279
Neisig A, Wubbolts R, Zang X, Melief C, Neefjes J (1996) Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 156:3196–3206
Nishimura C, Suzuki H, Tanaka N, Yamaguchi H (1989) Bleomycinhydrolase is a unique thiol aminopeptidase. Biochem Biophys Res Commun 163:788–796
Nishimura C, Tanaka N, Suzuki H (1987) Purification of bleomycin hydrolase with a monoclonal antibody and its characterization. Biochemistry 26:1574–1578
Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell P (1997) A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277:1306–1309
Papandreou CN, Logothetis CJ (2004) Bortezomib as a potential treatment for prostate cancer. Cancer Res 64:5036–5043
Princiotta MF, Finzi D, Qian SB, Gibbs J, Schuchmann S, Buttgereit F, Bennink JR, Yewdell JW(2003) Quantitating protein synthesis, degradation, endogenous antigen processing. Immunity 18:343–354
Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213–244
Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, Janssen H, Calafat J, Drijfhout JW, Neefjes J (2003) Peptide diffusion, protection, degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18:97–108
Reits E, Neijssen J, Herberts C, Benckhuijsen W, Janssen L, Drijfhout JW, Neefjes J (2004) A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 20:495–506
Reits EA, Griekspoor AC, Neefjes J (2000a) How does TAP pump peptides? Insights from DNA repair and traffic ATPases. Immunol Today 21:598–600
Reits EA, Neefjes JJ (2001) From fixed to FRAP: measuring protein mobility and activity in living cells. Nat Cell Biol 3:E145–E147
Reits EA, Vos JC, Gromme M, Neefjes J (2000b) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404:774–778
Renn SC, Tomkinson B, Taghert PH (1998) Characterization and cloning of tripeptidyl peptidase II from the fruit fly, Drosophila melanogaster. J Biol Chem 273:19173–19182
Roelse J, Gromme M, Momburg F, Hammerling G, Neefjes J (1994) Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J Exp Med 180:1591–1597
Saric T, Chang SC, Hattori A, York IA, Markant S, Rock KL, Tsujimoto M, Goldberg AL (2002) An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 3:1169–1176
Saric T, Graef CI, Goldberg AL (2004) Pathway for degradation of peptides generated by proteasomes: a key role for thimet oligopeptidase and other metallopeptidases. J Biol Chem 279:46273–46732
Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770–774
Schumacher TN, Kantesaria DV, Heemels MT, Ashton-Rickardt PG, Shepherd JC, Fruh K, Yang Y, Peterson PA, Tonegawa S, Ploegh HL (1994) Peptide length andsequence specificity of the mouse TAP1/TAP2 translocator. J Exp Med 179:533–540
Sebti SM, DeLeon JC, Lazo JS (1987) Purification, characterization, amino acid composition of rabbit pulmonary bleomycin hydrolase. Biochemistry 26:4213–4219
Sebti SM, Lazo JS (1987) Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases. Biochemistry 26:432–437
Serwold T, Gonzalez F, Kim J, Jacob R, Shastri N (2002) ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419:480–483
Shepherd JC, Schumacher TN, Ashton-Rickardt PG, Imaeda S, Ploegh HL, Janeway CA, Jr, Tonegawa S (1993) TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577–584
Spee P, Neefjes J (1997) TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin. Eur J Immunol 27:2441–2449
Spee P, Subjeck J, Neefjes J (1999) Identification of novel peptide binding proteins in the endoplasmic reticulum: ERp72, calnexin, grp170. Biochemistry 38:10559–10566
Suh WK, Cohen-Doyle MF, Fruh K, Wang K, Peterson PA, Williams DB (1994) Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322–1326
Thompson MW, Govindaswami M, Hersh LB (2003) Mutation of active site residues of the puromycin-sensitive aminopeptidase: conversion of the enzyme into a catalytically inactive binding protein. Arch Biochem Biophys 413:236–242
Thompson MW, Hersh LB (2003) Analysis of conserved residues of the human puromycin-sensitive aminopeptidase. Peptides 24:1359–1365
Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K (1989) Association of class Imajor histocompatibility heavy and light chains induced by viral peptides. Nature 340:443–448
Vos JC, Reits EA, Wojcik-Jacobs E, Neefjes J (2000) Head-head/tail-tail relative orientation of the pore-forming domains of the heterodimeric ABC transporter TAP. Curr Biol 10:1–7
Vos JC, Spee P, Momburg F, Neefjes J (1999) Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three-domain structure. J Immunol 163:6679–6685
Yewdell JW (2001) Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol 11:294–297
Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3:952–961
Yewdell JW, Schubert U, Bennink JR (2001) At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class Imolecules. J Cell Sci 114:845–851
York IA, Chang SC, Saric T, Keys JA, Favreau JM, Goldberg AL, Rock KL (2002) The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol 3:1177–1184
York IA, Mo AX, Lemerise K, Zeng W, Shen Y, Abraham CR, Saric T, Goldberg AL, Rock KL (2003) The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. Immunity 18:429–440
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Groothuis, T., Neefjes, J. (2006). The Ins and Outs of Intracellular Peptides and Antigen Presentation by MHC Class I Molecules. In: Wiertz, E., Kikkert, M. (eds) Dislocation and Degradation of Proteins from the Endoplasmic Reticulum. Current Topics in Microbiology and Immunology, vol 300. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28007-3_6
Download citation
DOI: https://doi.org/10.1007/3-540-28007-3_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28006-4
Online ISBN: 978-3-540-28007-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)